Skip to content

Recruiting to Clinical Trials on the Telephone

Recruiting to Clinical Trials on the Telephone

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02570061
Enrollment
125
Registered
2015-10-07
Start date
2013-07-31
Completion date
2014-02-28
Last updated
2015-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Newborn, Parental Consent, Vaccination

Keywords

recruitment, comprehension, satisfaction, informed consent, telephone

Brief summary

This study examined the use of the telephone for the purpose of informing expectant mothers about a randomized clinical trial assessing neonatal Bacille Calmette-Guérin vaccination. Expectant mothers who were contacted for participation in a vaccination trial (the Calmette study, NCT01694108) were randomized to receive information by telephone or at a face-to-face consultation. The primary outcome was a communication score, consisting of comprehension of information about the study and satisfaction with the information process. The outcome was measured using a questionnaire two weeks after the information was provided and two and a half months after birth.

Detailed description

Informed consent is an essential element of clinical research. Obtaining consent, however, may be challenging. The use of the telephone for giving information and obtaining consent may be practical but little formal research has been done. This study examined the use of the telephone for the purpose of informing expectant mothers about a randomized clinical trial assessing neonatal Bacille Calmette-Guérin vaccination. Expectant mothers who were contacted for participation in the Calmette Study were randomised to receive information by telephone or at a face-to-face consultation. The primary outcome was a communication score, consisting of comprehension of information about the study and satisfaction with the information process. The outcome was measured using a questionnaire two days after the information was provided and two and a half months after birth.

Interventions

BEHAVIORALtelephone

information given at the primary contact by phone, or at a scheduled later time

BEHAVIORALconsultation face-to-face

information given at a scheduled consultation at the hospital

Sponsors

Gorm Greisen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Planning to give birth at Rigshospitalet

Exclusion criteria

* Prior contact to the Calmette trial staff * Unable/unwilling to come to hospital for face-to-face information * Declining participation in this trial

Design outcomes

Primary

MeasureTime frameDescription
total communication score2 weeks after information was givenSum of scores of answers to all questions in a proprietary questionnaire

Secondary

MeasureTime frameDescription
comprehension subscore2 weeks after information was givencomprehension of trial-related information: sum of scores of answers
satisfaction subscore2 weeks after information was givensatisfaction with information process: sum of scores of answers

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026